Express News | GlycoMimetics Inc -on June 21, Got Notice From Nasdaq, Co Is Not in Compliance With Nasdaq’s Listing Rule 5450(a)(1)

ReutersJun 26 16:32 ET

Senior VP & Chief Medical Officer of GlycoMimetics Edwin Rock Buys 81% More Shares

Even if it's not a huge purchase, we think it was good to see that Edwin Rock, the Senior VP & Chief Medical Officer of GlycoMimetics, Inc. (NASDAQ:GLYC) recently shelled out US$79k to buy stock, at U

Simply Wall StJun 26 06:08 ET

Beyond Air XAIR Earnings; GlycoMimetics GLYC Insider Buys

BioPharmCatalystJun 25 16:02 ET

Why GlycoMimetics Stock Is Trading Higher Monday

GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock. The Details: On Tuesday, the chief medical officer Edwin Rock

BenzingaJun 25 12:06 ET

Trending Stocks Today: Volcon Soars 77.31% Pre-Market

June 25th - US stocks trending pre-market: Gainers: $Volcon(VLCN.US)$ soars 77.31% to $6.88 with a turnover of $13.82 million. $GlycoMimetics(GLYC.US)$ surges 43.47% to $0.38 with a turnover of $5.9 m

Moomoo NewsJun 25 07:30 ET

Trending Stocks Today: GlycoMimetics Shoots up 79.66% Post-Market

June 24th - US stocks trending post-market.Gainers: $GlycoMimetics(GLYC.US)$ shoots up 79.66% to $0.48 with a turnover of $8.3 million. $Recursion Pharmaceuticals(RXRX.US)$ climbs 4.38% to $9.75 with

Moomoo NewsJun 24 18:00 ET